Sorry @Stoof, was not trying to cast shade. But, to non American...

Sorry @Stoof, was not trying to cast shade.

But, to non American investors, your point should be amplified because your example is very common when a "growth stock" gains momentum on a USA market.

Even a stock like Nvidia, which is up 2100% in 36 months, is still considered a growth stock and traded yesterday at a p/e of 67 times earnings. Tesla as well, which is -35% off its one year high, trades at a p/e of 50.

Lynas listing on a US market would also open the door to higher share prices but also abundant capital recourses, much as had been the case with Molycorp and MP, respectively.

A US listing could easily generate a 30 p/e for Lynas, which on Fridays close would have the stock trading at AU$13.00 and US$10.00, before adjusting to ensure a $5.00 initial listing price.

All of this chat is an assumption given investor sentiment for our sector. Though, it seems almost impossible to imagine that the Lynas board has not considered this move for the 2nd or 3rd semester of 2024.